Christina Garnavou-Xirou, Georgios Bontzos, Georgios Smoustopoulos, Stavros Velissaris, Alexandros Papadopoulos, Efstathios Georgopoulos, Panagiotis Stavrakas, Tina Xirou, Vasileios Kozobolis
{"title":"视网膜分支静脉闭塞的眼部和遗传危险因素综述。","authors":"Christina Garnavou-Xirou, Georgios Bontzos, Georgios Smoustopoulos, Stavros Velissaris, Alexandros Papadopoulos, Efstathios Georgopoulos, Panagiotis Stavrakas, Tina Xirou, Vasileios Kozobolis","doi":"10.26574/maedica.2024.19.4.780","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Branch retinal vein occlusion (BRVO) is a leading cause of vision impairment globally and the second most common retinal vascular disease leading to blindness. Affecting over 20 million people worldwide, the prevalence of BRVO is expected to increase with the aging population. Branch retinal vein occlusion occurs due to the obstruction of small veins draining blood from the retina, leading to hemorrhages, fluid leakage and retinal damage. Its pathogenesis involves a complex interplay of ocular conditions and genetic predispositions.</p><p><strong>Methods: </strong>A comprehensive literature search was conducted using PubMed and Google Scholar for articles published between January 2010 and January 2024. The search terms included \"retinal vein occlusion\", \"BRVO\" and \"risk factors.\" After initial screening of 642 articles, non-English articles, animal studies and in vitro models were excluded. In total, 63 articles were analyzed for ocular and genetic risk factors associated with BRVO.</p><p><strong>Results: </strong>Ocular risk factors for BRVO include glaucoma, short axial length and optic disc drusen. Elevated intraocular pressure in glaucoma can compress retinal veins, while short axial length increases the likelihood of venous compression. Optic disc drusen cause vascular anomalies that heighten BRVO risk. Genetic polymorphisms affecting coagulation, endothelial function, inflammation and oxidative stress, such as MTHFR C677T and Factor V Leiden, also influence BRVO susceptibility. Familial clustering and genetic variations in inflammatory pathways further contribute to the risk.</p><p><strong>Conclusion: </strong>The significant impact of BRVO on vision health underscores the need for comprehensive strategies for early detection, prevention and treatment. Understanding the ocular and genetic risk factors is crucial for developing personalized treatment and effective public health initiatives. Ongoing research into genetic and molecular mechanisms will enhance management approaches and improve patient outcomes.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":"19 4","pages":"780-788"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11834831/pdf/","citationCount":"0","resultStr":"{\"title\":\"Ocular and Genetic Risk Factors in Branch Retinal Vein Occlusion: a Comprehensive Review.\",\"authors\":\"Christina Garnavou-Xirou, Georgios Bontzos, Georgios Smoustopoulos, Stavros Velissaris, Alexandros Papadopoulos, Efstathios Georgopoulos, Panagiotis Stavrakas, Tina Xirou, Vasileios Kozobolis\",\"doi\":\"10.26574/maedica.2024.19.4.780\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Branch retinal vein occlusion (BRVO) is a leading cause of vision impairment globally and the second most common retinal vascular disease leading to blindness. Affecting over 20 million people worldwide, the prevalence of BRVO is expected to increase with the aging population. Branch retinal vein occlusion occurs due to the obstruction of small veins draining blood from the retina, leading to hemorrhages, fluid leakage and retinal damage. Its pathogenesis involves a complex interplay of ocular conditions and genetic predispositions.</p><p><strong>Methods: </strong>A comprehensive literature search was conducted using PubMed and Google Scholar for articles published between January 2010 and January 2024. The search terms included \\\"retinal vein occlusion\\\", \\\"BRVO\\\" and \\\"risk factors.\\\" After initial screening of 642 articles, non-English articles, animal studies and in vitro models were excluded. In total, 63 articles were analyzed for ocular and genetic risk factors associated with BRVO.</p><p><strong>Results: </strong>Ocular risk factors for BRVO include glaucoma, short axial length and optic disc drusen. Elevated intraocular pressure in glaucoma can compress retinal veins, while short axial length increases the likelihood of venous compression. Optic disc drusen cause vascular anomalies that heighten BRVO risk. Genetic polymorphisms affecting coagulation, endothelial function, inflammation and oxidative stress, such as MTHFR C677T and Factor V Leiden, also influence BRVO susceptibility. Familial clustering and genetic variations in inflammatory pathways further contribute to the risk.</p><p><strong>Conclusion: </strong>The significant impact of BRVO on vision health underscores the need for comprehensive strategies for early detection, prevention and treatment. Understanding the ocular and genetic risk factors is crucial for developing personalized treatment and effective public health initiatives. Ongoing research into genetic and molecular mechanisms will enhance management approaches and improve patient outcomes.</p>\",\"PeriodicalId\":74094,\"journal\":{\"name\":\"Maedica\",\"volume\":\"19 4\",\"pages\":\"780-788\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11834831/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Maedica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.26574/maedica.2024.19.4.780\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Maedica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26574/maedica.2024.19.4.780","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
视网膜分支静脉阻塞(BRVO)是全球视力损害的主要原因,也是导致失明的第二大常见视网膜血管疾病。BRVO影响全球超过2000万人,随着人口老龄化,患病率预计会增加。视网膜分支静脉闭塞是由于视网膜上的小静脉供血受阻,导致出血、漏液和视网膜损伤。其发病机制涉及眼部状况和遗传易感性的复杂相互作用。方法:对2010年1月至2024年1月间发表的文章,通过PubMed和谷歌Scholar进行综合文献检索。搜索词包括“视网膜静脉阻塞”、“BRVO”和“危险因素”。初步筛选642篇文章后,排除非英文文章、动物研究和体外模型。共分析了63篇与BRVO相关的眼部和遗传危险因素。结果:BRVO的眼部危险因素包括青光眼、眼轴短和视盘塌陷。青光眼患者眼压升高可压迫视网膜静脉,而眼轴长度短则增加静脉压迫的可能性。视盘囊肿引起血管异常,增加BRVO风险。影响凝血、内皮功能、炎症和氧化应激的遗传多态性,如MTHFR C677T和Factor V Leiden,也会影响BRVO易感性。炎症途径中的家族聚类和遗传变异进一步增加了风险。结论:BRVO对视力健康有显著影响,需要制定早期发现、预防和治疗的综合策略。了解眼部和遗传风险因素对于制定个性化治疗和有效的公共卫生举措至关重要。正在进行的遗传和分子机制的研究将加强管理方法并改善患者的预后。
Ocular and Genetic Risk Factors in Branch Retinal Vein Occlusion: a Comprehensive Review.
Introduction: Branch retinal vein occlusion (BRVO) is a leading cause of vision impairment globally and the second most common retinal vascular disease leading to blindness. Affecting over 20 million people worldwide, the prevalence of BRVO is expected to increase with the aging population. Branch retinal vein occlusion occurs due to the obstruction of small veins draining blood from the retina, leading to hemorrhages, fluid leakage and retinal damage. Its pathogenesis involves a complex interplay of ocular conditions and genetic predispositions.
Methods: A comprehensive literature search was conducted using PubMed and Google Scholar for articles published between January 2010 and January 2024. The search terms included "retinal vein occlusion", "BRVO" and "risk factors." After initial screening of 642 articles, non-English articles, animal studies and in vitro models were excluded. In total, 63 articles were analyzed for ocular and genetic risk factors associated with BRVO.
Results: Ocular risk factors for BRVO include glaucoma, short axial length and optic disc drusen. Elevated intraocular pressure in glaucoma can compress retinal veins, while short axial length increases the likelihood of venous compression. Optic disc drusen cause vascular anomalies that heighten BRVO risk. Genetic polymorphisms affecting coagulation, endothelial function, inflammation and oxidative stress, such as MTHFR C677T and Factor V Leiden, also influence BRVO susceptibility. Familial clustering and genetic variations in inflammatory pathways further contribute to the risk.
Conclusion: The significant impact of BRVO on vision health underscores the need for comprehensive strategies for early detection, prevention and treatment. Understanding the ocular and genetic risk factors is crucial for developing personalized treatment and effective public health initiatives. Ongoing research into genetic and molecular mechanisms will enhance management approaches and improve patient outcomes.